Full-Time
Hematologist Oncologist
The Oncology Institute of Hope and Innovation
201-500 employees
Specialized, value-based cancer care provider
Compensation Overview
$500k - $650k/yr
Senior, Expert
Riverside, CA, USA
- Board Certified/Board Eligible in Hematology and Oncology
- Eligible for medical licensure in California
- Make a difference in the lives of patients
- Build relationships and provide support throughout patients' care journey
- Work within community-centered clinics
- Access Medical Director and extended Physician leadership team for support, collaboration, and guidance
- Participate in Tumor Boards and case discussions
- Engage in ongoing professional education with a collaborative Physician team
The Oncology Institute of Hope and Innovation (TOI) provides specialized cancer care to patients in their communities. Their services include clinical trials, transfusions, and various care delivery models that are typically found in advanced healthcare organizations. TOI employs over 90 clinicians and has a team of more than 700 staff members across 50 clinic locations, making it accessible to a large population of over 1.7 million patients. What sets TOI apart from other cancer care providers is its focus on value-based care, ensuring that patients receive high-quality treatment tailored to their needs. The goal of TOI is to improve cancer care by making it more accessible and effective for patients in their local communities.
Company Size
201-500
Company Stage
IPO
Headquarters
Cerritos, California
Founded
2007
Simplify's Take
What believers are saying
- TOI's AI partnership with Massive Bio empowers cancer research and patient care.
- TOI's digital therapeutics pipeline addresses cancer-related distress effectively.
- TOI's acquisition of SRON expands radiation oncology presence in Los Angeles.
What critics are saying
- TOI faces competition from other value-based oncology groups in Florida.
- Integration of House Rx's model may face operational challenges.
- SRON acquisition may lead to integration issues affecting patient care.
What makes The Oncology Institute of Hope and Innovation unique
- TOI's High-Value Cancer Care model reduces costs and hospitalizations.
- TOI's partnership with House Rx enhances pharmacy operations and patient access to therapies.
- TOI's Florida Oncology Network expands access to coordinated cancer care.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Hybrid Work Options
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 2%The Oncology Institute to participate at the B. Riley securities 25th Annual Institutional Investor Conference.
CERRITOS, Calif., May 08, 2025 (GLOBE NEWSWIRE) - The Oncology Institute, Inc. (NASDAQ: TOI)("TOI"), one of the largest value-based oncology groups in the United States, announced today that it has been selected to present an abstract at the upcoming ASCO Annual Meeting further validating cost savings and reduced hospitalizations associated with its unique High-Value Cancer Care (HVCC) model*.
CERRITOS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today proudly announced the launch of the Florida Oncology Network. This new fully delegated network will expand access to high-quality, coordinated cancer care for Florida residents.The Florida Oncology Network includes TOI Clinics and a robust panel of value-focused medical and radiation oncologists strategically located throughout the state. The network is designed to provide comprehensive cancer care that is accessible, affordable, and focused on outcomes for patients and payor partners.Under the delegated arrangement, TOI has partnered with Provider Network Solutions (PNS), the market leader in specialty MSO and third-party administrative services, and through its affiliates will provide claims administration and processing as well as network management. The collaboration brings together TOI’s nationally recognized clinical model and PNS’s deep experience supporting delegated provider networks in Florida. Together, the organizations will focus on improving patient outcomes, reducing unnecessary variation in care, and aligning incentives with value-based objectives.The Florida Oncology Network commences operations effective immediately, with plans to grow both its geographic footprint and patient reach across Florida throughout 2025
The Oncology Institute (NASDAQ: TOI) has secured a $16.5 million private placement from accredited investors, including existing investors, management, and Board Directors, expected to close on March 26, 2025. The placement involves units priced at $2.2084, consisting of two common stock shares and warrants. Deerfield Management will exchange $4.1 million of TOI's convertible notes for preferred shares and warrants. Proceeds will support organic growth and working capital needs.
Toi Management, LLCCERRITOS, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) has announced the appointment of Jeremy Castle, MBA, as Chief Operations Officer, effective September 5, 2023. In this role, Mr. Castle leads enterprise field and central operations, pharmacy, real estate, and practice integration, playing a key role in driving TOI’s success as a public company.Mr. Castle joins TOI with over 15 years of oncology industry experience, and has a track record of driving growth and profitability for multi-state physician groups